200 related articles for article (PubMed ID: 9721438)
1. Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs.
Soldin SJ
Clin Biochem; 1998 Jul; 31(5):381-4. PubMed ID: 9721438
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Oellerich M; Armstrong VW; Schütz E; Shaw LM
Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
[No Abstract] [Full Text] [Related]
3. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
Zhang Y; Zhang R
Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic monitoring of sirolimus: its contribution to optimal prescription.
Holt DW; Denny K; Lee TD; Johnston A
Transplant Proc; 2003 May; 35(3 Suppl):157S-161S. PubMed ID: 12742490
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
[TBL] [Abstract][Full Text] [Related]
7. International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring.
Holt DW; Armstrong VW; Griesmacher A; Morris RG; Napoli KL; Shaw LM; ; ;
Ther Drug Monit; 2002 Feb; 24(1):59-67. PubMed ID: 11805724
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation.
Holt DW
Curr Opin Nephrol Hypertens; 2002 Nov; 11(6):657-63. PubMed ID: 12394613
[TBL] [Abstract][Full Text] [Related]
9. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
[No Abstract] [Full Text] [Related]
10. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments.
Oellerich M; Armstrong VW
Ther Drug Monit; 2006 Dec; 28(6):720-5. PubMed ID: 17164686
[No Abstract] [Full Text] [Related]
11. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
[No Abstract] [Full Text] [Related]
13. Cyclosporine therapeutic drug monitoring.
Jensen SA; Dalhoff KP
Transplant Proc; 2001 Sep; 33(6):3003-5. PubMed ID: 11543826
[No Abstract] [Full Text] [Related]
14. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
[TBL] [Abstract][Full Text] [Related]
15. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
16. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
Vathsala A; Lu YM
Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
[No Abstract] [Full Text] [Related]
17. Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.
Charlton M
Hepatology; 2011 Jul; 54(1):3-5. PubMed ID: 21710471
[No Abstract] [Full Text] [Related]
18. Cyclosporine level: which single-point estimation of drug level is the best?
Sharma R; Kumar J; Ahmed M; Gupta A; Gulati S; Sharma AP; Bhandari M
Transplant Proc; 2001; 33(7-8):3124-5. PubMed ID: 11750343
[No Abstract] [Full Text] [Related]
19. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
Ventura E; Bonardet A; Pageaux GP; Mourad G; Cristol JP
Transplant Proc; 2009 Mar; 41(2):707-9. PubMed ID: 19328963
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
[No Abstract] [Full Text] [Related]
[Next] [New Search]